<?xml version="1.0" encoding="UTF-8"?>
<p>Tracing the progression of research on the potential utilization of convalescent plasma in COVID-19, 11 studies were identified in the clinicaltrials.gov register and their main features are summarized in Table 
 <xref rid="T2" ref-type="table">2</xref>    . Of these 11 studies, 6 were single-arm, 4 were randomized comparative studies, and 1 pertained to the expanded access status for convalescent plasma (NCT04338360). Various countries have been implicated in these studies, including the USA, China, Colombia, Iran, Italy, Mexico, and the Netherlands. If completed, these studies would examine a minimum total of 1106 patients. At present, 5 studies are either recruiting, enrolling by invitation, or active and providing expanded access; six studies are not yet recruiting.
</p>
